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Rag2−/− gamma c−/− mice
RAG-hu miceHIV-1 infection is characterized by life-long viral persistence and continued decline of helper CD4 T cells. The
new generation of humanized mouse models that encompass RAG-hu, hNOG and BLT mice have been shown
to be susceptible to HIV-1 infection and display CD4 T cell loss. Productive infection has been demonstrated
with both R5 and X4 tropic strains of HIV-1 via direct injection as well as mucosal exposure. However the
duration of infection in these mice was evaluated for a limited time lasting only weeks post infection, and it
is not established how long the viremia can be sustained, and if the CD4 T cell loss persists throughout the
life of the infected humanized mice. In the present study we followed the HIV-1 infected RAG-hu mice to
determine the long-term viral persistence and CD4 T cell levels. Our results showed that viremia persists life-
long lasting for more than a year, and that CD4 T cell levels display a continuous declining trend as seen in
the human. These studies provide a chronic HIV-1 infection humanized mouse model that can be used to
dissect viral latency, long-term drug evaluation and immune-based therapies.
© 2009 Elsevier Inc. All rights reserved.Introduction
Since HIV-1 causes disease only in the human, a number of
humanized mouse models have been developed through the years to
study the viral pathogenesis in human cells in vivo. In this regard, two
conventional human-mouse chimeric models, namely the hu-PBL-
SCIDmouse with transplanted adult human PBLs (Mosier et al., 1988),
and the SCID-hu mouse model with transplanted human thymus and
liver tissues (McCune et al., 1988) played an important role in HIV-1
pathogenesis studies using a human hemato-lymphoid system.
However, despite many notable successes, some limitations exist.
They lack multi-lineage human hematopoiesis and a functional
human immune system. Also, these models primarily mimic an
acute HIV infection with rapid CD4 T cell loss thus restricting
pathogenesis studies to a short-term period lasting only a few
weeks (Jamieson et al., 1996; Mosier, 1996).
Improved humanizedmousemodels have recently been developed
that can rectify the above limitations (Manz, 2007; Shultz et al., 2007).
These new models include the NOD/SCIDγc−/− and Rag2−/−γc−/−
strains reconstituted with human CD34 cells (hNOG and RAG-hu
mice). Transplantation of human CD34 hematopoietic stem cells into
conditioned neonatal mice leads to de novo multi-lineage humanes), sakkina@gmail.com
na@colostate.edu (R. Akkina).
Molecular Biology, Brigham
ll rights reserved.hematopoiesiswith the production of T cells, B cells anddendritic cells.
Furthermore, an improvement of the standard SCID-hu mouse model
involved transplantation of thymic and liver tissues under the kidney
capsule of NOD-SCIDmice followed by reconstitution with autologous
human CD34 cells (BLT mice) (Melkus et al., 2006). Multilineage
hematopoiesis with the generation of HIV-susceptible CD4 T cells,
macrophages,monocytes, and dendritic cells in addition to B cellswith
a capacity for primary human immune responses distinguish these
newer humanized mouse models from that of previous conventional
models (An et al., 2007; Baenziger et al., 2006; Brainard et al., 2009;
Gorantla et al., 2006; Kuruvilla et al., 2007; Melkus et al., 2006;
Tonomura et al., 2008; Traggiai et al., 2004; Watanabe et al., 2007). A
number of groups including ours have demonstrated the utility of
these humanized mice as improved models for HIV-1 infection by
showing chronic viremia lasting several weeks by both R5 and X4
tropic viral strains, virus replication in a variety of lymphoid and non-
lymphoid organs including thymus, lymph nodes, spleen, lung, gut-
associated lymphoid tissue, and male and female reproductive tracts.
Viral infection leads to gradual CD4 T cell depletion (An et al., 2007;
Baenziger et al., 2006; Berges et al., 2006, 2008; Brainard et al., 2009;
Choudhary et al., 2009; Denton et al., 2008; Gorantla et al., 2006; Jiang
et al., 2008; Kumar et al., 2008; Sun et al., 2007; VanDuyne et al., 2008;
Watanabe et al., 2007; Zhang et al., 2006). Furthermore, although not
robust enough to be protective, humoral and cellular immune
responses against HIV-1 could also be seen to some extent (Baenziger
et al., 2006; Brainard et al., 2009;Watanabe et al., 2007). Since human
cells populatemucosal tissues such as the gut and vaginal tracts in both
RAG-hu mice (Berges et al., 2008; Choudhary et al., 2009; Kwant-
Fig. 1. Long-term viremia following HIV-1 infection of RAG-hu mice. RAG-hu mice
infected with either X4 tropic HIV-1 (A) or R5 tropic HIV-1 (B) were bled periodically
and HIV-1 viremia was measured in plasma by Q-RT-PCR as described in methods.
Fig. 2. Detection of HIV-1 infected cells in chronically infected RAG-hu mice. Tissues from
HIV-1 infected RAG-humicewere subjected to in situ hybridization to detect viral RNA. Bone
marrow at 14 months post-infection with HIV-1 NL4-3 (B) or uninfected bone marrow (A).
Mesenteric lymph node at 16 months post-infection with HIV-1 BaL-1 (D) or uninfected
lymph node (C). 200× magniﬁcation shown in C,D and 100× magniﬁcation shown in A,B.
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2007), another innovation with these new humanized mouse models
has been the successful mucosal transmission of HIV-1 through both
vaginal and rectal routes (Berges et al., 2008; Denton et al., 2008; Sun
et al., 2007). In a recent report, RAG-hu mice were also shown to be
capable of giving rise to protective humanmucosal immune responses
when infected by HSV-2 by the vaginal route (Kwant-Mitchell et al.,
2009).
HIV-1 infection in the human is life-long and the virus is known to
persist even in the presence of aggressive anti-retroviral therapy.
Therefore, long-term infection studies in animal models would be of
signiﬁcance to experimentally evaluate the chronic effects of HIV on
the human immune system. Despite the above-mentioned important
innovations of HIV-1 infection of humanized mice, it is not clear how
long the viral infection can be sustained since little data has thus far
been reported for long-term HIV-1 infection. Nearly all studies have
been terminated by 8–16 weeks post-infection, with the longest-term
data available being viremia detected up to 30 weeks post-infection,
CD4 T cell loss through 24 weeks post-infection, and in situ
histological conﬁrmation of virus replication through 12 weeks
(Berges et al., 2006). In the current study, we provide data for long-
term HIV-1 infection of RAG-hu mice, with viremia measured up to
63 weeks post-infection, CD4 T cell depletion tracked through
51 weeks, and detection of virus replication in lymphoid organs
through 70 weeks post-infection. Our ﬁndings demonstrate that HIV-
1 infection persists for essentially the lifetime of the infected animal,
as seen in the human.
Results and discussion
RAG-hu mice sustain long-term chronic HIV-1 infection for more than
a year
HIV infected individuals carry the virus life-long since virus
susceptible cells such as CD4 T cells are generated on a continuous
basis and the ineffective immune response is not able to eliminate the
viral infection. Similarly, continued production of HIV-1-susceptible
cells in humanizedmice (RAG-humice) engraftedwith hematopoietic
stem cells is likely to result in a life-long viral infection, thus allowing
the study of the chronic viral effects as seen in HIV-infected humans.
The data presented herein were analyzed in retrospective fashion
as we monitored long-term infection in animals from various
experimental groups whichwere infected at different times, including
both intraperitoneal andmucosal infection. To determine the duration
of persistent HIV-1 infection in RAG-hu mice, we monitored long-
term levels of plasma viremia by Q-RT-PCR following infection with
either X4 or R5 virus. Our results showed that RAG-hu mice infected
with either X4 or R5 HIV-1 maintain detectable viremia for at least
63 weeks post-infection, the last time point analyzed (Fig. 1). The
mean peak viremia is about 8×105 RNA copies/ml plasma and occurs
at about 8–9 weeks post-infection, regardless of virus used or route of
infection (intraperitoneal or mucosal). Thereafter, while the infected
animals continue to be virus-positive, viral load tends to slowly
diminish over time. Long-term viral load data for representative mice
(correlatedwith infecting virus and route of infection) are provided in
the supplementary materials (Table S1). In total, a single plasma
sample was found to be negative by Q-RT-PCR (n=105), and that
animal later tested positive again. Some previous reports were unable
to detect HIV-1 viremia in some RAG-hu mice at later time points
(Gorantla et al., 2006; Van Duyne et al., 2008). However, the p24 ELISA
methodwas used in these studies as opposed to detection of viral RNA
by Q-RT-PCR. A recent study showed detection of viral RNA and
provirus in infected mice while p24 was undetectable by ELISA in the
same animals (Van Duyne et al., 2008). Therefore use of Q-RT-PCR is
clearly more sensitive than p24 ELISA for measurement of HIV-1
viremia in RAG-hu mice.To further conﬁrm the presence of HIV-1 infected cells during
chronic infection, animals infected with either R5 or X4 viruses were
sacriﬁced and histological sections of lymphoid organs were evalu-
ated. HIV-1 RNA was detected by in situ hybridization in the bone
marrow at 14 months post-infection with X4 virus (Fig. 2B), while
none was detected in uninfected bone marrow (Fig. 2A). Similarly,
HIV RNA was detected in the mesenteric lymph node at 16 months
post-infection with R5 virus (Fig. 2D), but not in uninfected
mesenteric lymph node (Fig. 2C). The viral load and in situ viral
detection data taken together, conﬁrmed that infected mice carry the
virus long-term, most likely lifelong.
RAG-hu mice display CD4 T cell depletion during chronic HIV-1 infection
CD4 T cell depletion is a hallmark of HIV infection in the human
and similar ﬁndings were noted in previous reports in infected
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depletion was seen to occur with either of the R5 or X4 HIV-1 strains
that use different co-receptors for viral entry. In the present study of
chronic infection lasting more than a year, our data showed that there
is an initial drop in peripheral blood CD4 T cell counts which occurs
around 6 weeks for X4 virus-infected and at 9 weeks for R5 virus-
infected animals (Fig. 3). A rebound then ensues, followed by periodic
rises and falls of CD4 T cell counts. However, the overall trend is a
gradual decrease in CD4 T cell levels, being more severe for X4 virus
than for R5 virus consistent with that seen in the human towards the
late stages of the disease when the X4 virus predominates (Tersmette
et al., 1989). Long-term CD4 depletion data for representative mice
(correlatedwith infecting virus and route of infection) are provided in
the supplementary materials (Table S2).
In summary, we have shown that RAG-hu mice infected with HIV-
1 sustain chronic viremia with associated CD4 T cell level ﬂuctuations.
To our knowledge, this is the ﬁrst report wherein long-term HIV-1
infection has been followed for more than a year. These ﬁndings
establish the utility of this humanized mouse model for long-term
pathogenesis and therapeutic studies and open new avenues for in
vivo investigation. For example, viral latency can be evaluated and its
elimination can be attempted. Also, long-term suppression of the
virus with novel anti-retrovirals currently in the pipeline can be more
effectively evaluated in vivo and potential drug resistant viruses can
be isolated and characterized after prolonged treatment. Furthermore,
viral evolution in vivo from R5 to X4 virus can be better studied in
addition to evaluating chronic immune activation and its possible
reversal.
Materials and methods
Generation of humanized Rag2−/−γc−/−(RAG-hu) mice
Humanized BALB/c-Rag2−/−γc−/−mice were prepared essential-
ly as described by Traggiai et al. (2004)with the exception that human
fetal liver-derived CD34 cells were used for engraftment (Akkina et al.,
1994). Human fetal liver-derived CD34 cells were puriﬁed andFig. 3. Long-term CD4 T cell depletion in the peripheral blood of RAG-hu mice. RAG-hu
mice infected with either X4 tropic HIV-1 (A) or R5 tropic HIV-1 (B) were bled
periodically and examined for CD4 T cell depletion by FACS analysis of peripheral blood
cells stained for human CD3 and CD4 markers. CD4:CD3 ratios were determined as
described in methods. Data in (A) represent a mean of 4.5 mice evaluated per time
point, while (B) represents a mean of 5.7 mice per time point.cultured for 1 day in cytokine media containing 25 ng each IL-3, IL-6
and SCF as described previously (Akkina et al., 1994). After irradiation
at 350 rads, 2- to 3-day-old neonatal mice were injected intrahepa-
tically with 0.25–1×106 CD34 cells. Transplanted mice were screened
for human cell engraftment at 12 weeks post-reconstitution. Periph-
eral blood was collected by tail bleed, red blood cells were lysed using
the Whole Blood Erythrocyte Lysing Kit (R and D Systems, Minnea-
polis, MN), and cells were stained with the human pan-leukocyte
marker CD45 and FACS analyzed to verify engraftment.
HIV-1 infection of humanized Rag2−/−γc−/− mice
Humanized mice were infected either intraperitonially or by
mucosal routes (intravaginally or intrarectally). For intraperitonial
infections, HIV-1 in a 100 μl volume was injected at least 12 weeks
after cell engraftment. Mice received either HIV-1 NL4-3 (1.2×105 i.
u.) or HIV-1 BaL-1 (0.9×105 i.u.), where infectious units were based
upon p24 ELISA titers (100 i.u. per 1 ng of p24). For mucosal infection,
mice were infected with cell-free HIV-1 strain BaL-1 (R5 tropic)
(Berges et al., 2008). Brieﬂy, vaginal infections were performed in a
volume of 50 μl (156 TCID50 of BaL-1 virus or 203 TCID50 of NL4-3) and
rectal infections were performed in a volume of 20 μl (BaL-1 virus at
62 TCID50; NL4-3 virus at 81 TCID50). TCID50 titers were determined
by limiting dilution and infection of GFP-expressing Ghost R3/X4/R5
cells.
Measurement of viral load in plasma
To detect cell-free HIV by Q-RT-PCR, RNA was extracted from 25 to
50 μl of plasma collected at different times post infection using the
QIAamp Viral RNA kit (Qiagen, Valencia, CA). cDNAs were produced
with Superscript III reverse transcriptase (Invitrogen, Carlsbad, CA)
using a primer set speciﬁc for the HIV LTR sequence, and Q-PCR was
performed with the same primer set and a LTR-speciﬁc probe (Rouet
et al., 2005) using Supermix UDG (Invitrogen, Carlsbad, CA).
Flow cytometry
FACS analysis was performed on EDTA-treated peripheral blood
samples. Erythrocytes were lysed using the Whole Blood Erythrocyte
Lysing Kit (R and D Systems, Minneapolis, MN) per themanufacturer's
protocol. To determine CD3:CD4 ratios, white blood cells were stained
for CD3 and CD4 markers and FACS analyzed. CD4 T cell levels were
calculated as a ratio of the entire CD3 population (CD4+CD3+: CD3+).
To establish baseline CD4 T cell levels, all mice were analyzed prior to
infection and baseline values for each mouse were standardized to
100%. The following antibodies were used: hCD45-FITC, hCD3-PE,
hCD4-PECy5 (Caltag).
In situ hybridization for HIV-1 RNA
In situ hybridization was performed on 4-μm formalin-ﬁxed,
parafﬁn-embedded tissue sections from bonemarrow or frozen tissue
sections from mesenteric lymph node from HIV-1 infected and
uninfected RAG-hu mice. At least three sections were evaluated
from each tissue. Hybridization was performed using digoxigenin-
labeled antisense and sense riboprobes speciﬁc for HIV-1 env (nt
6411-6752) and detected using nitro blue tetrazolium/5-bromo-4-
chloro-3-indolyl phosphate (NBT/BCIP) as reported previously
(Berges et al., 2005). Sections were lightly counterstained with
hematoxylin to enable visualization of nuclei.
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